上海人工智能实验室（上海AI实验室）近日联合上海交通大学医学院附属瑞金医院等合作伙伴，在“2023健康中国思南峰会”上发布了医疗多模态基础模型群“浦医2.0”（OpenMEDLab2.0）。这一全新的升级旨在为“跨领域、跨疾病、跨模态”的AI医疗应用提供更为强大的能力支持。
浦医2.0的发布，标志着中国在AI医疗领域的研究和应用迈出了重要的一步。这个医疗多模态基础模型群，通过一站式开源，实现了医疗大模型群的资源共享，将为医学研究提供强大的数据支持。同时，浦医2.0也将为跨领域、跨疾病、跨模态的AI医疗应用提供更为强大的能力支持，助力我国医疗健康事业的发展。
According to the official microblog of Shanghai AI Laboratory, the launch of OpenMEDLab2.0 aims to provide capability support for AI medical applications that span across different fields, diseases, and modalities. This significant upgrade of the medical multi-modal foundational model group is a major step forward in China’s AI medical research and application. By opening the resources of the large medical model group, it facilitates shared access to data, which will greatly enhance the support for medical research. Furthermore, OpenMEDLab2.0 will also provide stronger capability support for AI medical applications that cross fields, diseases, and modalities, boosting the development of China’s healthcare industry.
【来源】https://mp.weixin.qq.com/s/MxWbRvUS-fzgtK_UXCfWow
Views: 1